A large randomised controlled intervention trial to prevent gastric cancer by eradication of Helicobacter pylori in Linqu County, China: baseline results and factors affecting the eradication - PubMed (original) (raw)

Randomized Controlled Trial

doi: 10.1136/gutjnl-2015-309197. Epub 2015 May 18.

Lian Zhang 1, Markus Gerhard 2, Jun-ling Ma 1, Wei-dong Liu 3, Kurt Ulm 2, Jian-xi Wang 3, Lei Zhang 1, Yang Zhang 1, Monther Bajbouj 2, Lan-fu Zhang 3, Ming Li 3, Michael Vieth 4, Rui-yong Liu 3, Michael Quante 2, Le-hua Wang 3, Stepan Suchanek 5, Tong Zhou 1, Wei-xiang Guan 1, Roland Schmid 2, Meinhard Classen 6, Wei-cheng You 1

Affiliations

Randomized Controlled Trial

A large randomised controlled intervention trial to prevent gastric cancer by eradication of Helicobacter pylori in Linqu County, China: baseline results and factors affecting the eradication

Kai-feng Pan et al. Gut. 2016 Jan.

Abstract

Objective: To clarify the full range of benefits and adverse consequences of Helicobacter pylori eradication as a strategy for gastric cancer prevention, the community-based intervention trial was launched in Linqu County, China.

Design: A total of 184,786 residents aged 25-54 years were enrolled in this trial and received (13)C-urea breath test. H. pylori positive participants were assigned into two groups, either receiving a 10-day quadruple anti-H. pylori treatment or lookalike placebos together with a single dosage of omeprazole and bismuth.

Results: The prevalence of H. pylori in trial participants was 57.6%. A total of 94,101 subjects completed the treatment. The overall H. pylori eradication rate was 72.9% in the active group. Gender, body mass index, history of stomach disease, baseline delta over baseline-value of (13)C-urea breath test, missed medication doses, smoking and drinking were independent predictors of eradication failure. The missed doses and high baseline delta over baseline-value were important contributors in men and women (all Ptrend<0.001). However, a dose-response relationship between failure rate and smoking or drinking index was found in men (all Ptrend<0.001), while high body mass index (Ptrend<0.001) and history of stomach disease were significant predictors in women. The treatment failure rate increased up to 48.8% (OR 2.87, 95% CI 2.24 to 3.68) in men and 39.4% (OR 2.67, 95% CI 1.61 to 4.42) in women with multiple factors combined.

Conclusions: This large community-based intervention trial to eradicate H. pylori is feasible and acceptable. The findings of this trial lead to a distinct evaluation of factors influencing eradication that should be generally considered for future eradication therapies.

Trial registration number: ChiCTR-TRC-10000979 in accordance with WHO ICTRP requirements.

Keywords: GASTRIC CANCER; HELICOBACTER PYLORI.

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

PubMed Disclaimer

Publication types

MeSH terms

Substances

LinkOut - more resources